Health Holland Research Grant Awarded

Aug 8, 2019

Funding for a 2-year research collaboration entitled “Improved personalized vaccines against cancer: quality of T cell immunity matters” has been awarded by Health Holland.

In this project Immunetune will collaborate with Leiden University Medical Center to further optimize cancer vaccines by inclusion of specific CD4 helper epitopes.

Immunetune joins the fight against Sars-CoV-2

Immunetune joins the fight against Sars-CoV-2

Within a newly established consortium, Immunetune will develop enhanced DNA vaccines against SARS-CoV-2 and other human coronaviruses. The vaccine is built on the combination of two strong synthetic vaccine platforms and the inclusion of conserved T and B cell...

read more